Investment Thesis

Aflac Incorporated is rated a STRONG BUY at current prices. The market is underestimating Aflac’s robust business model, characterized by its dual-segment strategy in Japan and the U.S., which provides a diversified revenue stream. The company’s consistent focus on supplemental health insurance allows it to capture a growing market share in an underpenetrated sector, positioning it well for sustainable long-term growth.

Competitive Moat

primarily based on intangible assets such as brand recognition and regulatory advantages. With a storied history and a trusted brand, Aflac benefits from low switching costs and high customer loyalty, especially in Japan, where it holds a significant market share in supplemental insurance. Over the next 5-10 years, these advantages are likely to remain intact, although the emergence of insurtech disruptors poses a potential threat by offering more agile and technologically advanced solutions.

Growth Engine

Future revenue growth for Aflac is expected to stem from the expansion of its product offerings and geographic footprint. The total addressable market for supplemental health and life insurance is projected to grow significantly, driven by aging demographics and rising healthcare costs. The company is currently gaining market share, particularly in the U.S., where it can leverage its existing distribution channels to introduce new products and services. Organic growth remains strong, with plans for targeted marketing campaigns and enhanced digital capabilities to reach underserved markets.